End of coverage

From 27th of September 2023, we will no longer include Veom Group in our coverage universe.

Steady progress in improving revenue mix

VEOM has reported Q2 2023 sales down 7% yoy. While Chacon & DIO Home sustained good momentum, Cabasse Audio (-18% yoy) faced a slowdown in retail sales. We remain cautious regarding H2 2023 amid a deteriorating macroeconomic outlook for consumer spending, but we anticipate successful product la

Bryan, Garnier & Co Technology Daily | CPGI, SOW, COP, ALVGV, SEMIS

ONWARD: from brainGPT to ARC-BCI – fireside chat with the founders

Yesterday, we hosted an exclusive fireside chat at our Paris HQ with ONWARD's co-founders, Dr. Grégoire Courtine and Dr. Jocelyne Bloch, accompanied by institutional investors, to learn about the professional endeavours that led them to jump from researchers to entrepreneurs, with a special deep-di

Avantium: joint-development progress in textiles

Yesterday, Avantium announced the successful development of a PEF-based spacer fabric in collaboration with partners Auping, Muller Textiles, Antex and Monosuisse. This breathable, cushioning 3D material marks a step forward for this partnership, ongoing since 2024, aiming to create PEF-based yarns

Egetis: Article highlights Emcitate's broad efficacy in MCT8 deficiency

A recent publication in Nature Communications (Groeneweg, van Geest et al. 2025) highlights the broad therapeutic applicability of Emcitate across the heterogeneity of the MCT8 deficient target group and supporting its uniform treatment eligibility across a genetically diverse patient population. I